Catalyst Pharmaceuticals Inc (CPRX)
21.69
-1.11
(-4.87%)
USD |
NASDAQ |
Nov 14, 16:00
21.55
-0.14
(-0.65%)
After-Hours: 20:00
Catalyst Pharmaceuticals Net Income (TTM): 142.80M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 142.80M |
| June 30, 2024 | 68.15M |
| March 31, 2024 | 65.12M |
| December 31, 2023 | 71.41M |
| September 30, 2023 | 62.04M |
| June 30, 2023 | 115.55M |
| March 31, 2023 | 99.41M |
| December 31, 2022 | 83.08M |
| September 30, 2022 | 66.92M |
| June 30, 2022 | 54.50M |
| March 31, 2022 | 45.06M |
| December 31, 2021 | 39.48M |
| September 30, 2021 | 41.61M |
| June 30, 2021 | 74.62M |
| March 31, 2021 | 72.22M |
| December 31, 2020 | 74.98M |
| September 30, 2020 | 71.48M |
| June 30, 2020 | 41.77M |
| March 31, 2020 | 42.95M |
| December 31, 2019 | 31.88M |
| September 30, 2019 | 9.446M |
| June 30, 2019 | -12.02M |
| March 31, 2019 | -28.95M |
| December 31, 2018 | -34.00M |
| September 30, 2018 | -24.89M |
| Date | Value |
|---|---|
| June 30, 2018 | -21.23M |
| March 31, 2018 | -19.15M |
| December 31, 2017 | -18.41M |
| September 30, 2017 | -17.19M |
| June 30, 2017 | -16.96M |
| March 31, 2017 | -17.65M |
| December 31, 2016 | -18.07M |
| September 30, 2016 | -19.72M |
| June 30, 2016 | -20.22M |
| March 31, 2016 | -20.21M |
| December 31, 2015 | -20.23M |
| September 30, 2015 | -17.91M |
| June 30, 2015 | -18.47M |
| March 31, 2015 | -17.11M |
| December 31, 2014 | -15.51M |
| September 30, 2014 | -13.37M |
| June 30, 2014 | -14.28M |
| March 31, 2014 | -14.22M |
| December 31, 2013 | -12.15M |
| September 30, 2013 | -10.88M |
| June 30, 2013 | -7.586M |
| March 31, 2013 | -4.732M |
| December 31, 2012 | -4.076M |
| September 30, 2012 | -6.352M |
| June 30, 2012 | -4.858M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
31.88M
Minimum
Dec 2019
142.80M
Maximum
Sep 2024
68.25M
Average
67.53M
Median
Net Income (TTM) Benchmarks
| Corcept Therapeutics Inc | 141.82M |
| Sarepta Therapeutics Inc | 121.84M |
| Alnylam Pharmaceuticals Inc | -332.26M |
| Biomarin Pharmaceutical Inc | 322.29M |
| Cytokinetics Inc | -576.40M |